PAREXEL International Corporation · Waltham, MA United States (NASDAQ: PRXL)
| 195 West St. | Phone: 781-487-9900 |
| Waltham, MA | Fax: 781-768-5512 |
| 02451 | |
| United States | 
Map This Company |
PAREXEL International Corporation Rankings
| S&P 600 |
Company Description
PAREXEL International excels in biopharmaceutical development services. A top contract research organization (CRO), the firm counts among its clients some of the world's largest drug, biotech, and medical device firms. Its Clinical Research Services segment's offerings include clinical trial and data management, study design, patient recruitment, biostatistical analysis, clinical pharmacology, and industry training and publishing. PAREXEL Consulting and Medical Communications Services handles the non-clinical aspects of drug development, regulatory affairs, and new product launches. Its
PAREXEL International Corporation Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: PRXL Headquarters |
|---|---|
| Fiscal Year-End | June |
| 2011 Employees | 10,550 |
Executives
129 executives listed for PAREXEL International Corporation's Waltham, MA location.
| Chairman and CEO | Josef von Rickenbach | |
|---|---|---|
| COO; President Clinical Research Services | Mark Goldberg | |
| SVP and CFO | James Winschel |